E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2018 in the Prospect News Bank Loan Daily and Prospect News Investment Grade Daily.

S&P reviews Shire, Takeda

S&P said it placed its BBB-/A-3 issuer credit and issue ratings on Shire plc on CreditWatch with positive implications and placed its A-/A-2 issuer credit and issue ratings on Takeda Pharmaceutical Co. on CreditWatch with negative implications.

The agency said the CreditWatch placement follows Takeda's announcement that it plans to acquire Shire for about £46 billion.

“We believe that Takeda's financial burden to fund the acquisition will significantly outweigh the expected benefits to its business risk profile, unless it takes measures to mitigate the financial burden,” S&P said in a news release.

The agency said it placed Shire on CreditWatch positive because it believes that the combined group's credit profile will likely improve compared to Shire's current one.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.